Completed Heart, Stroke & Blood Diabetes, Hormones & Metabolism

A program for prevention and treatment of resistant hypertension with algorithm based therapy (PATHWAY)

Funder BHF Charity-funded
Recipient organisation Queen Mary University of London Source-published name: Queen Mary, University of London
Funding £2.6M
Period Jan 2009 — Sept 2017

About this grant

This summary is based on the grant title only — the full abstract was not available.

Research project funded by BHF at Queen Mary University of London.

View the original record at the funder ↗

Researchers

Morris Brown (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

The TARGET BP I Trial: A Phase 2, Multicenter, Double-Blinded, Sham-Procedure Controlled Trial of Renal Denervation by the Peregrine Systemâ„¢ Kit , in Subjects with Hypertension
Personalised pharmacometabolomic optimisation of treatment for hypertension
Personalised pharmacometabolomic optimisation of treatment for hypertension (HYPERMARKER)
Improving the management and understanding of hypertension in primary care
Improving treatment efficacy in hypertension by biomarker-guided personalised decision support (HT- ADVANCE)

Original classification

None

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.